KARI RISCHLING: Open Payments
NPI 1013323922 · HUNTINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 40 payments from 17 companies in 2025. Trend: 2023 $686 · 2024 $795 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $214 |
| Abbott Laboratories | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| Dexcom, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Tonix Medicines, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: UBRELVY, FREESTYLE LIBRE 3, VRAYLAR, QULIPTA, SPRAVATO, Dexcom G6 Transmitter, Auvelity, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
